{
 "generic_name": "Imipenem Anhydrous, Cilastatin, and Relebactam Anhydrous Injection",
 "slug": "imipenem-anhydrous-cilastatin-and-relebactam-680eea",
 "brand_names": [
  "Recarbrio"
 ],
 "fda_status": [
  "To Be Discontinued"
 ],
 "last_fda_update": "09/09/2026",
 "first_posted": "09/09/2026",
 "synced_at": "2026-10-01T04:04:04.751Z",
 "presentations": [
  {
   "company": "Merck Sharp & Dohme LLC",
   "package_ndc": "0006-3856-02",
   "presentation": "RECARBRIO, Injection, 500 mg/100 mL; 500 mg/100 mL; 250 mg/100 mL (NDC 0006-3856-02)",
   "availability": "Not specified",
   "availability_raw": null,
   "fda_note": "To be discontinued on or near late September 2026."
  }
 ],
 "changes": []
}